Table of Content

1 Study Coverage
1.1 Onychomycosis (Tinea Unguium) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type
1.4.2 Oral Medication
1.4.3 External Medicine
1.3 Market by Application
1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Application
1.3.2 Age under 18
1.3.3 Age 18-50
1.3.4 Age above 50
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales
2.4.1 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales (2016-2021)
2.4.2 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales (2022-2027)
2.5 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue
2.5.1 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers
3.1.1 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Sales in 2020
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers
3.2.1 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Revenue in 2020
3.3 Global Onychomycosis (Tinea Unguium) Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Onychomycosis (Tinea Unguium) Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Type
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Historical Sales by Type (2016-2021)
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Type
4.2.1 Global Onychomycosis (Tinea Unguium) Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
4.3 Global Onychomycosis (Tinea Unguium) Drug Price by Type
4.3.1 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2016-2021)
4.3.2 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Application
5.1.1 Global Onychomycosis (Tinea Unguium) Drug Historical Sales by Application (2016-2021)
5.1.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Application
5.2.1 Global Onychomycosis (Tinea Unguium) Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
5.3 Global Onychomycosis (Tinea Unguium) Drug Price by Application
5.3.1 Global Onychomycosis (Tinea Unguium) Drug Price by Application (2016-2021)
5.3.2 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Application (2022-2027)

6 North America
6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type
6.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2027)
6.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2027)
6.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application
6.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2027)
6.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2027)
6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
6.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2027)
6.3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type
7.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2017-2027)
7.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2017-2027)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application
7.2.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2017-2027)
7.2.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2017-2027)
7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2017-2027)
7.3.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type
8.1.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Type (2018-2027)
8.1.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2018-2027)
8.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application
8.2.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Application (2018-2027)
8.2.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2018-2027)
8.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.3.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2018-2027)
8.3.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type
9.1.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Type (2019-2027)
9.1.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2019-2027)
9.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application
9.2.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2027)
9.2.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2019-2027)
9.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country
9.3.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2027)
9.3.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type
6.1.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2027)
6.1.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2027)
6.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application
6.2.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2027)
6.2.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2027)
6.3 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
6.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2027)
6.3.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 UAE

11 Company Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Corporation Information
11.1.2 Johnson and Johnson Overview
11.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Description
11.1.5 Johnson and Johnson Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 GSK Onychomycosis (Tinea Unguium) Drug Product Description
11.2.5 GSK Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Novartis Onychomycosis (Tinea Unguium) Drug Product Description
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Onychomycosis (Tinea Unguium) Drug Product Description
11.4.5 Pfizer Related Developments
11.5 Valeant Pharma
11.5.1 Valeant Pharma Corporation Information
11.5.2 Valeant Pharma Overview
11.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Description
11.5.5 Valeant Pharma Related Developments
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Corporation Information
11.6.2 Kaken Pharmaceutical Overview
11.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
11.6.5 Kaken Pharmaceutical Related Developments
11.7 Galderma
11.7.1 Galderma Corporation Information
11.7.2 Galderma Overview
11.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Galderma Onychomycosis (Tinea Unguium) Drug Product Description
11.7.5 Galderma Related Developments
11.8 Xiuzheng Pharmaceutical
11.8.1 Xiuzheng Pharmaceutical Corporation Information
11.8.2 Xiuzheng Pharmaceutical Overview
11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
11.8.5 Xiuzheng Pharmaceutical Related Developments
11.9 Letai
11.9.1 Letai Corporation Information
11.9.2 Letai Overview
11.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Letai Onychomycosis (Tinea Unguium) Drug Product Description
11.9.5 Letai Related Developments
11.10 Qilu Pharmaceutical
11.10.1 Qilu Pharmaceutical Corporation Information
11.10.2 Qilu Pharmaceutical Overview
11.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
11.10.5 Qilu Pharmaceutical Related Developments
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Corporation Information
11.1.2 Johnson and Johnson Overview
11.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Description
11.1.5 Johnson and Johnson Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Onychomycosis (Tinea Unguium) Drug Value Chain Analysis
12.2 Onychomycosis (Tinea Unguium) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Onychomycosis (Tinea Unguium) Drug Production Mode & Process
12.4 Onychomycosis (Tinea Unguium) Drug Sales and Marketing
12.4.1 Onychomycosis (Tinea Unguium) Drug Sales Channels
12.4.2 Onychomycosis (Tinea Unguium) Drug Distributors
12.5 Onychomycosis (Tinea Unguium) Drug Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Onychomycosis (Tinea Unguium) Drug Industry Trends
13.2 Onychomycosis (Tinea Unguium) Drug Market Drivers
13.3 Onychomycosis (Tinea Unguium) Drug Market Challenges
13.4 Onychomycosis (Tinea Unguium) Drug Market Restraints

14 Key Findings in The Global Onychomycosis (Tinea Unguium) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral Medication
Table 3. Major Manufacturers of External Medicine
Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) & (K Units)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) & (K Units)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2022-2027)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2021)
Table 12. Global Onychomycosis (Tinea Unguium) Drug Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2022-2027)
Table 14. Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers (2016-2021)
Table 16. Global Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2016-2021)
Table 18. Onychomycosis (Tinea Unguium) Drug Price by Manufacturers 2016-2021 (USD/Unit)
Table 19. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2020)
Table 21. Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Onychomycosis (Tinea Unguium) Drug Product Offered
Table 23. Date of Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2016-2021)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2022-2027)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2016-2021)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2022-2027)
Table 33. Onychomycosis (Tinea Unguium) Drug Price by Type (2016-2021) & (USD/Unit)
Table 34. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2016-2021)
Table 38. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2022-2027)
Table 39. Global Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2016-2021)
Table 42. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2022-2027)
Table 43. Onychomycosis (Tinea Unguium) Drug Price by Application (2016-2021) & (USD/Unit)
Table 44. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Application (2022-2027) & (USD/Unit)
Table 45. North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 46. North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 47. North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 50. North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 51. North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 54. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2022-2027) & (K Units)
Table 55. North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 58. Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 59. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 62. Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 63. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 66. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2022-2027) & (K Units)
Table 67. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2022-2027) & (US$ Million)
Table 105. Johnson and Johnson Corporation Information
Table 106. Johnson and Johnson Description and Major Businesses
Table 107. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product
Table 109. Johnson and Johnson Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GSK Onychomycosis (Tinea Unguium) Drug Product
Table 114. GSK Recent Developments
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Novartis Onychomycosis (Tinea Unguium) Drug Product
Table 119. Novartis Recent Developments
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Major Businesses
Table 122. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Onychomycosis (Tinea Unguium) Drug Product
Table 124. Pfizer Recent Developments
Table 125. Valeant Pharma Corporation Information
Table 126. Valeant Pharma Description and Major Businesses
Table 127. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product
Table 129. Valeant Pharma Recent Developments
Table 130. Kaken Pharmaceutical Corporation Information
Table 131. Kaken Pharmaceutical Description and Major Businesses
Table 132. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 134. Kaken Pharmaceutical Recent Developments
Table 135. Galderma Corporation Information
Table 136. Galderma Description and Major Businesses
Table 137. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Galderma Onychomycosis (Tinea Unguium) Drug Product
Table 139. Galderma Recent Developments
Table 140. Xiuzheng Pharmaceutical Corporation Information
Table 141. Xiuzheng Pharmaceutical Description and Major Businesses
Table 142. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 144. Xiuzheng Pharmaceutical Recent Developments
Table 145. Letai Corporation Information
Table 146. Letai Description and Major Businesses
Table 147. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 148. Letai Onychomycosis (Tinea Unguium) Drug Product
Table 149. Letai Recent Developments
Table 150. Qilu Pharmaceutical Corporation Information
Table 151. Qilu Pharmaceutical Description and Major Businesses
Table 152. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 153. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 154. Qilu Pharmaceutical Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 158. Onychomycosis (Tinea Unguium) Drug Customers List
Table 159. Onychomycosis (Tinea Unguium) Drug Market Trends
Table 160. Onychomycosis (Tinea Unguium) Drug Market Drivers
Table 161. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 162. Onychomycosis (Tinea Unguium) Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Onychomycosis (Tinea Unguium) Drug Product Picture
Figure 2. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type in 2020 & 2027
Figure 3. Oral Medication Product Picture
Figure 4. External Medicine Product Picture
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020 & 2027
Figure 6. Age under 18
Figure 7. Age 18-50
Figure 8. Age above 50
Figure 9. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 10. Global Onychomycosis (Tinea Unguium) Drug Sales 2016-2027 (K Units)
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue 2016-2027 (US$ Million)
Figure 13. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2022-2027)
Figure 16. North America Onychomycosis (Tinea Unguium) Drug Sales YoY (2016-2027) & (K Units)
Figure 17. North America Onychomycosis (Tinea Unguium) Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Onychomycosis (Tinea Unguium) Drug Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Onychomycosis (Tinea Unguium) Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Onychomycosis (Tinea Unguium) Drug Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Onychomycosis (Tinea Unguium) Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Onychomycosis (Tinea Unguium) Drug Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2020
Figure 28. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 30. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 31. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 32. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 33. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 34. North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 35. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 36. North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 37. North America Onychomycosis (Tinea Unguium) Drug Sales Share by Country (2016-2027)
Figure 38. North America Onychomycosis (Tinea Unguium) Drug Revenue Share by Country (2016-2027)
Figure 39. U.S. Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 42. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 43. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 44. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 45. Europe Onychomycosis (Tinea Unguium) Drug Sales Share by Country (2016-2027)
Figure 46. Europe Onychomycosis (Tinea Unguium) Drug Revenue Share by Country (2016-2027)
Figure 47. Germany Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 48. France Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Region (2016-2027)
Figure 58. China Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 61. India Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Philippines Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 69. Latin America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 71. Latin America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Onychomycosis (Tinea Unguium) Drug Sales Share by Country (2016-2027)
Figure 73. Latin America Onychomycosis (Tinea Unguium) Drug Revenue Share by Country (2016-2027)
Figure 74. Mexico Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Share by Country (2016-2027)
Figure 83. Turkey Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Onychomycosis (Tinea Unguium) Drug Revenue (2016-2027) & (US$ Million)
Figure 86. Onychomycosis (Tinea Unguium) Drug Value Chain
Figure 87. Onychomycosis (Tinea Unguium) Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed